Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
On one hand, specifically blocking HIF signaling can significantly attenuate hypoxia-driven pathological ROS accumulation
AOD 9604 is meant for subcutaneous injection, not intramuscular
It is considered an investigational compound and is typically sold by research chemical suppliers under the label for research purposes only
The regulatory status of BPC-157 varies by country: it is not approved as a medication but remains accessible as a research peptide in certain jurisdictions
doi:10.1056/NEJMoa1301467 Hu S, Yu Q, Wang Y, Wang M, Xia W, Zhu C
US$ 20.57
US$ 20.06
US$ 28.76
US$ 29.77
US$ 25.92
US$ 21.24
US$ 26.52
US$ 29.10
US$ 22.72
US$ 27.47
US$ 22.69
US$ 26.79
